Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Beachler

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
JAMA Pediatrics|May 22, 2023
Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 YearsMao Hu, Hui Lee Wong, Yuhui Feng, et al.
Vaccine|February 22, 2024
Incidence rates of thrombosis with thrombocytopenia syndrome (TTS) among adults in United States commercial and Medicare claims databases, 2017-2020Patricia C Lloyd, Bradley Lufkin, Keran Moll, et al.
Vaccine|October 4, 2022
Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 yearsPatricia C Lloyd, Mao Hu, Hui-Lee Wong, et al.
JAMA Network Open|April 24, 2024
Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 YearsMao Hu, Azadeh Shoaibi, Yuhui Feng, et al.
Vaccine|August 22, 2025
Safety monitoring of health outcomes following influenza vaccination during the 2023-2024 season among U.S. Commercially-insured individuals aged 6 months through 64 years: Self-controlled case series analysesPatricia C Lloyd, Gyanada Acharya, Henu Zhao, et al.
Cell|September 9, 2017
HPV16 E7 Genetic Conservation Is Critical to CarcinogenesisLisa Mirabello, Meredith Yeager, Kai Yu, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
JAMA Pediatrics|May 22, 2023
Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 YearsMao Hu, Hui Lee Wong, Yuhui Feng, et al.
Vaccine|February 22, 2024
Incidence rates of thrombosis with thrombocytopenia syndrome (TTS) among adults in United States commercial and Medicare claims databases, 2017-2020Patricia C Lloyd, Bradley Lufkin, Keran Moll, et al.
Vaccine|October 4, 2022
Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 yearsPatricia C Lloyd, Mao Hu, Hui-Lee Wong, et al.
JAMA Network Open|April 24, 2024
Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 YearsMao Hu, Azadeh Shoaibi, Yuhui Feng, et al.
Vaccine|August 22, 2025
Safety monitoring of health outcomes following influenza vaccination during the 2023-2024 season among U.S. Commercially-insured individuals aged 6 months through 64 years: Self-controlled case series analysesPatricia C Lloyd, Gyanada Acharya, Henu Zhao, et al.
Cell|September 9, 2017
HPV16 E7 Genetic Conservation Is Critical to CarcinogenesisLisa Mirabello, Meredith Yeager, Kai Yu, et al.
Pageof 6